Status:
UNKNOWN
Study of the Development of Human Immune System of Newborns by Antigen Chips
Lead Sponsor:
Sheba Medical Center
Collaborating Sponsors:
Weizmann Institute of Science
Conditions:
Antibody Immune Profile
Eligibility:
All Genders
1-7 years
Brief Summary
The immune system is a dynamic, constantly evolving network. Excluding autoimmune diseases, healthy individuals are also known to have a large number of circulating antibodies that can recognize prote...
Detailed Description
Antibody reactivities are traditionally studied by their individual reactivities to one or only a few antigens, whereas only a small number of studies have focused on the repertoires of antibodies to ...
Eligibility Criteria
Inclusion
- Term and preterm newborns and their mothers
- Age 1 day to 7 weeks
Exclusion
- Maternal immune dieases
- Major congential malformations
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00843648
Start Date
March 1 2009
End Date
March 1 2011
Last Update
February 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Ramat Gan, Israel, 52621